Stanley J Szefler
Overview
Explore the profile of Stanley J Szefler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
318
Citations
9020
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Skeen E, Skeen E, Hamlington K, De Keyser H, De Keyser H, Liu A, et al.
Ann Allergy Asthma Immunol
. 2025 Feb;
PMID: 40010666
Discussions on asthma management tend to focus on the therapeutic aspects when updates on asthma strategies are released. However, many other components of asthma management are now receiving increased attention,...
2.
Fuhlbrigge A, Szefler S
J Allergy Clin Immunol Pract
. 2025 Feb;
13(2):308-309.
PMID: 39922678
No abstract available.
3.
De Keyser H, De Keyser H, Anderson 3rd W, Stempel D, Szefler S
J Allergy Clin Immunol Pract
. 2025 Jan;
PMID: 39824439
Digital health is an umbrella term for components of health care using computer platforms, software, connectivity, and sensors to augment the recording, documentation, and communication of clinical information. The functions...
4.
Chan A, De Keyser H, Horne R, Szefler S
Eur Respir J
. 2024 Nov;
65(1.
PMID: 39603674
No abstract available.
5.
Pavord I, Rabe K, Israel E, Szefler S, Brusselle G, Pandit-Abid N, et al.
J Allergy Clin Immunol Pract
. 2024 Oct;
13(1):132-142.
PMID: 39424189
Background: Remission is proposed as a multicomponent outcome for patients with severe asthma. Objective: This post hoc analysis of QUEST (NCT02414854) and TRAVERSE (NCT02134028) evaluated whether dupilumab treatment leads to...
6.
Navanandan N, Jackson N, Hamlington K, Everman J, Pruesse E, Secor E, et al.
J Allergy Clin Immunol Pract
. 2024 Oct;
13(1):95-104.e5.
PMID: 39368548
Background: Although respiratory viruses are common triggers of asthma exacerbations, the influence of viral infection characteristics on exacerbation presentation and treatment response in the pediatric emergency department (ED) is unclear....
7.
Huebschmann A, Wagner N, Gleason M, Brinton J, Brtnikova M, Brewer S, et al.
Implement Sci
. 2024 Aug;
19(1):60.
PMID: 39148094
Background: Asthma is a leading cause of children's hospitalizations, emergency department visits, and missed school days. Our school-based asthma intervention has reduced asthma exacerbations for children experiencing health disparities in...
8.
Papadopoulos N, Bacharier L, Jackson D, Deschildre A, Phipatanakul W, Szefler S, et al.
J Allergy Clin Immunol Pract
. 2024 Jun;
12(9):2310-2324.
PMID: 38878861
Increased understanding of the underlying pathophysiology has highlighted the heterogeneity of asthma and identified that most children with asthma have type 2 inflammation with elevated biomarkers, such as blood eosinophils...
9.
Szefler S
J Allergy Clin Immunol Pract
. 2024 Jun;
12(6):1547-1548.
PMID: 38851252
No abstract available.
10.
Brewer S, DeCamp L, Reedy J, Armstrong R, DeKeyser H, Federico M, et al.
Ethn Dis
. 2024 Jun;
DECIPHeR(Spec Issue):126-131.
PMID: 38846737
Background: School-based asthma programs effectively address poorly controlled asthma and asthma disparities, especially when coupled with screening for and addressing social determinants of health (SDOH) needs. Existing screening tools are...